{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/MIRM/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T05:35:16.367Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":6943,"canonical_name":"Mirum Pharmaceuticals, Inc.","cik":"0001759425","uei":null,"lei":null,"duns":null,"ticker":"MIRM"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":54,"clinical":1},"count":55,"timeline":[{"ts":"2026-08-11","kind":"sec.form144","reporter":"ERIC BJERKHOLT","title":"Officer","shares":6001,"usd_value":599510,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001950047-26-007935","importance":40.1199019},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":11683,"price_per_share":98.51,"usd_value":1150892,"security_title":"Common Stock","importance":36.15089233},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":6017,"price_per_share":99.25,"usd_value":597187,"security_title":"Common Stock","importance":35.59718725},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":2300,"price_per_share":100.14,"usd_value":230322,"security_title":"Common Stock","importance":35.230322},{"ts":"2026-08-10","kind":"sec.insider.m","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":20000,"price_per_share":2.936,"usd_value":58720,"security_title":"Common Stock","importance":15.05872},{"ts":"2026-07-06","kind":"sec.form144","reporter":"CHRISTOPHER PEETZ","title":"Officer, Director","shares":20000,"usd_value":2445434,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001950047-26-006855","importance":40.4890868},{"ts":"2026-07-06","kind":"sec.form144","reporter":"ERIC BJERKHOLT","title":"Officer","shares":5000,"usd_value":611270,"security_title":"Common","approx_sale_date":"2026-07-06","accession_number":"0001950047-26-006854","importance":40.122254},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":12134,"price_per_share":121.65,"usd_value":1476101,"security_title":"Common Stock","importance":36.4761011},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":4181,"price_per_share":122.34,"usd_value":511504,"security_title":"Common Stock","importance":35.51150354},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":3124,"price_per_share":121.67,"usd_value":380097,"security_title":"Common Stock","importance":35.38009708},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":1975,"price_per_share":123.74,"usd_value":244387,"security_title":"Common Stock","importance":35.2443865},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":1710,"price_per_share":124.79,"usd_value":213391,"security_title":"Common Stock","importance":35.2133909},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":1048,"price_per_share":122.43,"usd_value":128307,"security_title":"Common Stock","importance":35.12830664},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":528,"price_per_share":123.84,"usd_value":65388,"security_title":"Common Stock","importance":35.06538752},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":300,"price_per_share":124.94,"usd_value":37482,"security_title":"Common Stock","importance":35.037482},{"ts":"2026-07-06","kind":"sec.insider.m","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":20000,"price_per_share":2.936,"usd_value":58720,"security_title":"Common Stock","importance":15.05872},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Mirum Pharmaceuticals, Inc. — 2026-07-02","url_slug":"/sec/cik-0001759425/4/0001974200-26-000010","accession_number":"0001974200-26-000010","importance":30},{"ts":"2026-07-01","kind":"sec.form144","reporter":"JOLANDA MARIE HOWE","title":"Officer","shares":2721,"usd_value":326520,"security_title":"Common","approx_sale_date":"2026-07-01","accession_number":"0001950047-26-006797","importance":40.065304},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Howe Jolanda","title":"SVP, GLOBAL CONTROLLER","shares":2721,"price_per_share":120,"usd_value":326520,"security_title":"Common Stock","importance":35.32652},{"ts":"2026-07-01","kind":"sec.filing","form_type":"144","title":"144 — Mirum Pharmaceuticals, Inc. — 2026-07-01","url_slug":"/sec/cik-0001759425/144/0001950047-26-006797","accession_number":"0001950047-26-006797","importance":30},{"ts":"2026-06-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Mirum Pharmaceuticals, Inc. — 2026-06-18","url_slug":"/sec/cik-0001759425/8-k/0001193125-26-275811","accession_number":"0001193125-26-275811","importance":35},{"ts":"2026-06-18","kind":"sec.filing","form_type":"4","title":"4 — Mirum Pharmaceuticals, Inc. — 2026-06-18","url_slug":"/sec/cik-0001759425/4/0001974200-26-000009","accession_number":"0001974200-26-000009","importance":30},{"ts":"2026-06-17","kind":"sec.form144","reporter":"JOLANDA MARIE HOWE","title":"Officer","shares":2594,"usd_value":264458,"security_title":"Common","approx_sale_date":"2026-06-17","accession_number":"0001950047-26-006244","importance":40.05289166},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Howe Jolanda","title":"SVP, GLOBAL CONTROLLER","shares":2594,"price_per_share":101.95,"usd_value":264458,"security_title":"Common Stock","importance":35.2644583},{"ts":"2026-06-17","kind":"sec.filing","form_type":"144","title":"144 — Mirum Pharmaceuticals, Inc. — 2026-06-17","url_slug":"/sec/cik-0001759425/144/0001950047-26-006244","accession_number":"0001950047-26-006244","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Fairey William — 2026-06-17","url_slug":"/sec/cik-0001727275/4/0001727275-26-000004","accession_number":"0001727275-26-000004","importance":30},{"ts":"2026-06-17","kind":"sec.filing","form_type":"4","title":"4 — Mirum Pharmaceuticals, Inc. — 2026-06-17","url_slug":"/sec/cik-0001759425/4/0001854337-26-000004","accession_number":"0001854337-26-000004","importance":30},{"ts":"2026-06-09","kind":"sec.insider.m","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":2393,"price_per_share":26.49,"usd_value":63391,"security_title":"Common Stock","importance":15.06339057},{"ts":"2026-06-08","kind":"sec.form144","reporter":"ERIC BJERKHOLT","title":"Officer","shares":5000,"usd_value":469073,"security_title":"Common","approx_sale_date":"2026-06-08","accession_number":"0001950047-26-005748","importance":40.0938146},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":2258,"price_per_share":92.84,"usd_value":209633,"security_title":"Common Stock","importance":35.20963272},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":1567,"price_per_share":95.12,"usd_value":149053,"security_title":"Common Stock","importance":35.14905304},{"ts":"2026-06-08","kind":"sec.insider.s","reporter":"BJERKHOLT ERIC","title":"CHIEF FINANCIAL OFFICER","shares":1175,"price_per_share":93.95,"usd_value":110391,"security_title":"Common Stock","importance":35.11039125},{"ts":"2026-06-05","kind":"sec.insider.m","reporter":"Radovich Peter","title":"PRESIDENT AND COO","shares":16988,"price_per_share":19.19,"usd_value":326000,"security_title":"Common Stock","importance":15.32599972},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Mirum Pharmaceuticals, Inc. — 2026-06-02","url_slug":"/sec/cik-0001759425/4/0001854337-26-000002","accession_number":"0001854337-26-000002","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"CHRISTOPHER PEETZ","title":"Officer, Director","shares":30000,"usd_value":2875107,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005448","importance":40.5750214},{"ts":"2026-06-01","kind":"sec.form144","reporter":"SAIRA RAMASASTRY","title":"Director","shares":3977,"usd_value":397700,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005336","importance":40.07954},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":16595,"price_per_share":95.34,"usd_value":1582167,"security_title":"Common Stock","importance":36.5821673},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":6926,"price_per_share":96.15,"usd_value":665935,"security_title":"Common Stock","importance":35.6659349},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Ramasastry Saira","title":"","shares":3977,"price_per_share":100,"usd_value":397700,"security_title":"Common Stock","importance":35.3977},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":2602,"price_per_share":94.64,"usd_value":246253,"security_title":"Common Stock","importance":35.24625328},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":1973,"price_per_share":97.56,"usd_value":192486,"security_title":"Common Stock","importance":35.19248588},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":1021,"price_per_share":98.2,"usd_value":100262,"security_title":"Common Stock","importance":35.1002622},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":883,"price_per_share":99.66,"usd_value":88000,"security_title":"Common Stock","importance":35.08799978},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Peetz Christopher","title":"CHIEF EXECUTIVE OFFICER","shares":30000,"price_per_share":2.936,"usd_value":88080,"security_title":"Common Stock","importance":15.08808},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Walbert Timothy P","title":"","shares":3977,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Fischer Laurent","title":"","shares":3977,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Ramasastry Saira","title":"","shares":3977,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-29","kind":"sec.insider.m","reporter":"Cardon Lon","title":"","shares":3977,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Mirum Pharmaceuticals, Inc. — 2026-05-18","url_slug":"/sec/cik-0001759425/8-k/0001193125-26-228902","accession_number":"0001193125-26-228902","importance":35},{"ts":"2026-05-15","kind":"sec.form144","reporter":"SAIRA RAMASASTRY","title":"Director","shares":2000,"usd_value":218940,"security_title":"Common","approx_sale_date":"2026-05-15","accession_number":"0001950047-26-004580","importance":40.043788},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"Ramasastry Saira","title":"","shares":2000,"price_per_share":109.47,"usd_value":218940,"security_title":"Common Stock","importance":35.21894},{"ts":"2026-05-15","kind":"sec.insider.m","reporter":"Ramasastry Saira","title":"","shares":2000,"price_per_share":23.51,"usd_value":47020,"security_title":"Common Stock","importance":15.04702},{"ts":"2026-05-01","kind":"clinical.trial","reporter":"Mirum Pharmaceuticals, Inc.","title":"Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide","security_title":"PHASE2,PHASE3","status":"RECRUITING","accession_number":"NCT07454837","excerpt":"[\"Chronic Hepatitis D\"]","importance":60},{"ts":"2026-04-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Mirum Pharmaceuticals, Inc. — 2026-04-27","url_slug":"/sec/cik-0001759425/8-k/0001193125-26-179048","accession_number":"0001193125-26-179048","importance":35},{"ts":"2026-04-27","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Mirum Pharmaceuticals, Inc. — 2026-04-27","url_slug":"/sec/cik-0001759425/schedule-13g-a/0002012383-26-001752","accession_number":"0002012383-26-001752","importance":30}]}